Muya Xiong

State Key Laboratory Of Drug Research
Shanghai, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 21 publications

Structure-Based Development of Ultra-Broad-Spectrum 3C-Like Protease Inhibitors.

Structure-Based Development of Ultra-Broad-Spectrum 3C-Like Protease Inhibitors.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Published: July 04, 2025

Dynamic Cap-Mediated Substrate Access and Potent Inhibitor Design of Monkeypox Virus I7L Protease.

Dynamic Cap-Mediated Substrate Access and Potent Inhibitor Design of Monkeypox Virus I7L Protease.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Published: January 25, 2025

Potency Prediction of Covalent Inhibitors against SARS-CoV-2 3CL-like Protease and Multiple Mutants by Multiscale Simulations.

Potency Prediction of Covalent Inhibitors against SARS-CoV-2 3CL-like Protease and Multiple Mutants by Multiscale Simulations.

Journal: Journal of chemical information and modeling

Published: November 28, 2024

De novo design of protein condensation inhibitors by targeting an allosteric site of cGAS.

De novo design of protein condensation inhibitors by targeting an allosteric site of cGAS.

Journal: Nature communications

Published: September 20, 2024

Structure-based design of potent and selective inhibitors targeting RIPK3 for eliminating on-target toxicity in vitro.

Structure-based design of potent and selective inhibitors targeting RIPK3 for eliminating on-target toxicity in vitro.

Journal: Nature communications

Published: August 19, 2024

Benzbromarone interferes with the interaction between Hsp90 and Aha1 by interacting with both of them.

Benzbromarone interferes with the interaction between Hsp90 and Aha1 by interacting with both of them.

Journal: Communications biology

Published: May 15, 2024

Discovery of novel cGAS inhibitors based on natural flavonoids.

Discovery of novel cGAS inhibitors based on natural flavonoids.

Journal: Bioorganic chemistry

Published: June 27, 2023

Discovery of Novel 5,6-Dihydro-1,2,4-triazine Derivatives as Efficacious Glucagon-Like Peptide-1 Receptor Agonists.

Discovery of Novel 5,6-Dihydro-1,2,4-triazine Derivatives as Efficacious Glucagon-Like Peptide-1 Receptor Agonists.

Journal: Journal of medicinal chemistry

Published: June 07, 2023

Structure-based development and preclinical evaluation of the SARS-CoV-2 3C-like protease inhibitor simnotrelvir.

Structure-based development and preclinical evaluation of the SARS-CoV-2 3C-like protease inhibitor simnotrelvir.

Journal: Nature communications

Published: April 18, 2023

Structure-Based Design of Potent Peptidomimetic Inhibitors Covalently Targeting SARS-CoV-2 Papain-like Protease.

Structure-Based Design of Potent Peptidomimetic Inhibitors Covalently Targeting SARS-CoV-2 Papain-like Protease.

Journal: International journal of molecular sciences

Published: February 27, 2023

Unraveling the catalytic mechanism of SARS-CoV-2 papain-like protease with allosteric modulation of C270 mutation using multiscale computational approaches.

Unraveling the catalytic mechanism of SARS-CoV-2 papain-like protease with allosteric modulation of C270 mutation using multiscale computational approaches.

Journal: Chemical science

Published: January 11, 2023

Multi-omics for COVID-19: driving development of therapeutics and vaccines.

Multi-omics for COVID-19: driving development of therapeutics and vaccines.

Journal: National science review

Published: November 27, 2022

Showing 1-12 of 21

Last Updated: 09/26/2026